Other Clinical Trial - An Observational Study to Identify New Health

Status Active, not recruiting

Clinical Trial Summary

This is an observational study in which data already collected from people with acute respiratory distress syndrome (ARDS) admitted to an intensive care unit (ICU) are studied. ARDS is a life-threatening condition in which fluid builds up in the lungs making breathing difficult. In observational studies, only observations are made without participants receiving any advice or any changes to health care. People who are admitted to ICU for serious illnesses, like ARDS, often experience new health problems during and after their ICU stays. These health problems that may include physical, mental, and/or emotional disorders, are called post-intensive care syndrome (PICS). Identifying these new health problems early can help people by timely treatments and care. In this study, researchers want to identify any health problems that arise after ICU admission in people with ARDS in the United States (US). To do this, researchers will collect information on health problems, treatments, medicines, and healthcare visits in people with ARDS, 1 year before and after an ICU admission. They will then look to see whether the health problems are in areas that have been described as the post intensive care syndrome (PICS). In addition, they will measure healthcare related costs in the one year after admission and compare it to the one year prior to admission. Researchers will also compare this information with data collected for people with pneumonia who did not require ICU admission. This will help them to identify any new health problems arising due to ICU stays. The data will come from participants' medical claims information stored in the Optum Clinformatics Data Mart database from 2016 to 2022. The claims data will only be collected for people in the US. Researchers will collect data from participants admitted to ICU for ARDS for a maximum of 1 year before and after their stay.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Acute Lung Injury
Acute Respiratory Distress Syndrome (ARDS)
Post Intensive Care Syndrome (PICS)
Respiratory Distress Syndrome
Respiratory Distress Syndrome, Newborn
Syndrome

Clinical Trial Details

NCT number	NCT06272942
Study type	Observational
Source	Bayer
Contact
Status	Active, not recruiting
Phase
Start date	January 31, 2024
Completion date	August 30, 2025

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03909854` - Pragmatic Investigation of Volume Targeted Ventilation-1	N/A
Recruiting	`NCT02637011` - Surviving ARDS: The Influence of Quality of Care and Individual Patient Characteristics on Quality of Life	N/A
Completed	`NCT02288949` - Stratification of the Acute Respiratory Distress Syndrome
Recruiting	`NCT02574169` - Alveolar Recruitment Maneuvers, Intracerebral Hemodynamic and Oxygenation	N/A
Completed	`NCT04548739` - Cerebral Autoregulation in Pediatric ECMO (ECMOX 2)
Completed	`NCT05024500` - Clinical and Functional Outcomes of Critically Ill Patients With COVID-19	N/A
Terminated	`NCT04511650` - Evaluation of the Safety and Efficacy of Razuprotafib in Hospitalized Subjects With Coronavirus Disease 2019	Phase 2
Recruiting	`NCT01339533` - Airway Pressure Release Ventilation (APRV) Versus AC/VC Conventional Ventilation	Phase 2
Active, not recruiting	`NCT01274260` - Trial of Steroids in Pediatric Acute Lung Injury/ARDS	Phase 2
Recruiting	`NCT03296059` - Transfusion of Red Blood Cells for Acute Respiratory Distress Syndrome(ARDS) in Neonates	N/A
Recruiting	`NCT04609865` - Impact of Intravenous Lidocaine on Clinical Outcomes of Patients With ARDS During COVID-19 Pandemia	Phase 3
Active, not recruiting	`NCT04009330` - Clinical Evaluation of a Point of Care (POC) Assay to Identify Phenotypes in the Acute Respiratory Distress Syndrome
Not yet recruiting	`NCT05847517` - Metoprolol in Acute Respiratory Distress Syndrome (MAIDEN)	Phase 3
Not yet recruiting	`NCT06127381` - An Open-label Study of the Safety and Pharmacokinetics of the TGKP	Phase 1
Completed	`NCT01854424` - Validation of the Percentage of Alveolar Fibrocyte as Biomarker During ARDS	N/A
Completed	`NCT03870009` - Validation of a Semi-automatized Method to Detect Cyclic Hyperinflation on CT-scan in ARDS	N/A
Completed	`NCT04311697` - Intravenous Aviptadil for Critical COVID-19 With Respiratory Failure	Phase 2/Phase 3
Recruiting	`NCT02095444` - Using Human Menstrual Blood Cells to Treat Acute Lung Injury Caused by H7N9 Bird Flu Virus Infection	Phase 1/Phase 2
Recruiting	`NCT04460859` - RecruitmEnt Assessed by eleCtRical Impedance Tomography
Completed	`NCT01926093` - Low Dose Lung CT Scan for Quantitative Analysis in ARDS Patients	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

An Observational Study to Identify New Health Problems Arising After an Intensive Care Unit Admission in People With Acute Respiratory Distress Syndrome in the United States — SeeMe Tool

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms